Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
The AAPS Journal|June 27, 2006
Interaction of dicaproyl phosphatidylserine with recombinant factor VIII and its impact on immunogenicityVivek S Purohit, Sathyamangalam V BalasubramanianClinical Pharmacokinetics|February 15, 2024
Moving Beyond Boundaries: Utilization of Longitudinal Exposure-Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development ParadigmYeamin Huh, Jessica Wojciechowski, Vivek S PurohitPharmaceutical Research|March 23, 2024
Pharmacokinetic Profile of Brepocitinib with Topical Administration in Atopic Dermatitis and Psoriasis Populations: Strategy to Inform Clinical Trial Design in Adult and Pediatric PopulationsFarzaneh Maleki, Cheng Chang, Vivek S Purohit, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 3, 2014
Intravenous administration of Factor VIII-O-Phospho-L-Serine (OPLS) complex reduces immunogenicity and preserves pharmacokinetics of the therapeutic proteinPuneet Gaitonde, Vivek S Purohit, Sathy V Balu-IyerJournal of Pharmaceutical Sciences|December 24, 2005
Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A miceVivek S Purohit, C Russell Middaugh, Sathyamangalam V BalasubramanianJournal of Clinical Pharmacology|December 18, 2018
Systemic Tofacitinib Concentrations in Adult Patients With Atopic Dermatitis Treated With 2% Tofacitinib Ointment and Application to Pediatric Study PlanningVivek S Purohit, William C Ports, Cunshan Wang, et al.The AAPS Journal|October 3, 2007
O-phospho-L-serine, multi-functional excipient for B domain deleted recombinant factor VIIIRazvan D Miclea, Vivek S Purohit, Sathy V Balu-IyerClinical Pharmacokinetics|November 2, 2023
Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug DevelopmentJessica Wojciechowski, Vivek S Purohit, Yeamin Huh, et al.The Journal of Biological Chemistry|February 25, 2005
Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-L-serine complexVivek S Purohit, Karthik Ramani, Rita Sarkar, et al.Pageof 3